NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.freeradbiomed.2021.07.022
PubMed Identifier: 34314817
Publication URI: http://europepmc.org/abstract/MED/34314817
Type: Journal Article/Review
Volume: 173
Parent Publication: Free radical biology & medicine
ISSN: 0891-5849